• Research Topics

  RNS60 Added to the HEALEY ALS Platform Trial

  Posted by Richard on February 24, 2021 at 9:35 am

  Hi All, came across an article about RNS60, it’s being added to the HEALEY ALS Platform Trial.  RNS60 is a novel neuroprotective and immune-modulatory agent that has shown significant effects in pre-clinical models of ALS and other neurodegenerative diseases. Hoping for some positive outcomes.

  https://www.massgeneral.org/news/press-release/Revalesio-signs-agreement-to-design-trial-with-rns60-for-the-healeyals-platform-trial

   

  Richard

   

  Richard replied 3 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply